Skip to main content

Advertisement

SpringerLink
Log in

Mesenchymal Stem Cells Derived from Human Amniotic Membrane Increase VEGF and Extenuate Fibrosis in Heart Failure Rats

  • Research Paper
  • Published:
Iranian Journal of Science and Technology, Transactions A: Science Aims and scope Submit manuscript

Abstract

Heart failure (HF) is a leading cause of death that has remained incurable. Recently, stem cell therapy has emerged as a promising tool in cardiac regenerative medicine. Human amniotic membrane-derived mesenchymal stem cells (hAMSCs) with unique characteristics can be used in HF treatment. Here, we aimed to examine the effects of hAMSCs transplantation on cardiac fibrosis in a rat model of ISO-induced HF. Forty male Wistar rats were divided into four groups: sham, isoproterenol-induced HF ((Iso)-)ISO, ISO + culture medium, and ISO + hAMSCs. HF was induced by subcutaneous injection of isoproterenol 170 mg/kg/d in 4 consecutive days. Four weeks later, in ISO + hAMSCs, 3 × 106 hAMSCs were injected into the myocardium, whereas the ISO + culture medium was only injected by cell culture medium. Finally, cardiac functions and hemodynamic parameters were measured. Immunohistochemistry (IHC), Western blot, and histological assessment were performed to evaluate myocardial fibrosis and detect vascular endothelial growth factor (VEGF) collagen type I and III expression level. HF model caused a decrease in ejection fraction (EF) and fraction shortening, whereas both were increased after hAMSCs transplantation. IHC and Western blot and Western blot analyses confirmed that hAMSCs could attenuate fibrosis, reduce collagen I and III depositions, and increase VEGF expression. Intramyocardial transplantation of hAMSCs improves cardiac functions and myocardial structure caused by HF. A rise in VEGF expression presents hAMSCs as a compatible source of stem cell therapy for HF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Availability of Data and Material

The authors confirm that the data supporting the findings of this study are available within the article [and/or] its supplementary materials.

Code Availability

Not applicable.

References

  • Afousi AG, Gaeini A, Rakhshan K, Naderi N, Azar AD, Aboutaleb N (2019) ’Targeting necroptotic cell death pathway by high-intensity interval training (HIIT) decreases development of post-ischemic adverse remodelling after myocardial ischemia/reperfusion injury. J Cell Commun Signal 13:255–267

    Google Scholar 

  • Bulati M, Miceli V, Gallo A, Amico G, Carcione C, Pampalone M, Conaldi PG (2020) The immunomodulatory properties of the human amnion-derived mesenchymal stromal/stem cells are induced by INF-γ produced by activated lymphomonocytes and are mediated by cell-to-cell contact and soluble factors. Front Immunol 11:54

    Google Scholar 

  • Cai B, Tan X, Zhang Y, Li X, Wang X, Zhu J, Wang Y, Yang F, Wang B, Liu Y (2015) Mesenchymal stem cells and cardiomyocytes interplay to prevent myocardial hypertrophy. Stem Cells Trans Med 4:1425–1435

    Google Scholar 

  • Failla CM, Carbo M, Morea V (2018) Positive and negative regulation of angiogenesis by soluble vascular endothelial growth factor receptor-1. Int J Mol Sci 19:1306

    Google Scholar 

  • Ge Q, Zhang H, Hou J, Wan L, Cheng W, Wang X, Dong D, Chen C, Xia J, Guo J (2018) VEGF secreted by mesenchymal stem cells mediates the differentiation of endothelial progenitor cells into endothelial cells via paracrine mechanisms. Mol Med Reports 17:1667–1675

    Google Scholar 

  • Gunawardena TN, Abeysinghe MT, Rahman BJ, Abdullah J, Kasim NHA (2019) Conditioned media derived from mesenchymal stem cell cultures: The next generation for regenerative medicine. J Tissue Eng Regen Med 13:569–586

    Google Scholar 

  • Guo Y, Yunsheng Y, Shijun H, Chen Y, Shen Z (2020) The therapeutic potential of mesenchymal stem cells for cardiovascular diseases. Cell Death Disease 11:1–10

    Google Scholar 

  • Jain M, Minocha E, Tripathy NK, Singh N, Chaturvedi CP, Nityanand S (2019) Comparison of the cardiomyogenic potency of human amniotic fluid and bone marrow mesenchymal stem cells. Int J Stem Cells 12:449

    Google Scholar 

  • Jiao J, Tian W, Qiu P, Norton EL, Wang MM, Eugene Chen Y, Yang B (2018) Induced pluripotent stem cells with NOTCH1 gene mutation show impaired differentiation into smooth muscle and endothelial cells: implications for bicuspid aortic valve-related aortopathy. J Thorac Cardiovasc Surg 156:515–522

    Google Scholar 

  • Joo HJ, Kim J-H, Hong SJ (2017) ’Adipose tissue-derived stem cells for myocardial regeneration. Korean Circul J 47:151

    Google Scholar 

  • Karbasiafshar C, Sellke FW, Ruhul Abid M (2021) Mesenchymal stem cell-derived extracellular vesicles in the failing heart: past, present, and future. Physiol-Heart Circul Physiol 320:H1999–H2010

    Google Scholar 

  • Kheila M, Gorjipour F, Gohari LH, Sharifi M, Abotaleb N (2021) ’Human mesenchymal stem cells derived from amniotic membrane attenuate isoproterenol (ISO)-induced myocardial injury by targeting apoptosis. Med J Islam Republ Iran’ 35:650–56

    Google Scholar 

  • Li LL, Peng C, Zhang M, Liu Y, Li H, Huibo Chen Y, Sun CZ, Zhang Y (2018) Mesenchymal stem cells overexpressing adrenomedullin improve heart function through antifibrotic action in rats experiencing heart failure. Mol Med Reports 17:1437–44

    Google Scholar 

  • Li L, Zhao Q, Kong W (2018) Extracellular matrix remodeling and cardiac fibrosis. Matrix Biol 68:490–506

    Google Scholar 

  • Li L, Zhang S, Zhang Y, Bo Y, Yan X, Guan ZZ (2009) Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Mol Biol Reports 36:725–731

    Google Scholar 

  • Li S, Hao X, Xiao S, Xun L (2020) The effect of YiQiFuMai on ischemic heart failure by improve myocardial microcirculation and increase eNOS and VEGF expression. Int J Clin Med 11:84

    Google Scholar 

  • Maleki SN, Aboutaleb N, Nazarinia D, Beik SA, Qolamian A, Nobakht M (2019) Conditioned medium obtained from human amniotic membrane-derived mesenchymal stem cell attenuates heart failure injury in rats. Iran J Basic Med Sci 22:1253

    Google Scholar 

  • Martins IJ (2016) Anti-aging genes improve appetite regulation and reverse cell senescence and apoptosis in global populations. Adv Aging Res 5(1):9–26. https://doi.org/10.4236/aar.2016.51002

    Article  Google Scholar 

  • Martins IJ (2017) Single gene inactivation with implications to diabetes and multiple organ dysfunction syndrome. J Clin Epigenet 3:100058

    Google Scholar 

  • Martins IJ (2017) ’Nutrition therapy regulates caffeine metabolism with relevance to NAFLD and induction of type 3 diabetes. J Diabetes Metab Disord 4:1–9

    Google Scholar 

  • Mary G, Van de Walle A, Perez JE, Ukai T, Maekawa T, Luciani N, Wilhelm C (2020) High-throughput differentiation of embryonic stem cells into cardiomyocytes with a microfabricated magnetic pattern and cyclic stimulation. Adv Funct Mater 30:2002541

    Google Scholar 

  • Mead B, Tomarev S (2017) Bone marrow-derived mesenchymal stem cells-derived exosomes promote survival of retinal ganglion cells through miRNA-dependent mechanisms. Stem Cells Trans Med 6:1273–1285

    Google Scholar 

  • Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, Miyahara Y, Fujii T, Uematsu M, Ohgushi H, Yamagishi M (2005) ’Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112:1128–1135

    Google Scholar 

  • Nakata TM, Suzuki K, Uemura A, Shimada K, Tanaka R (2019) Contrasting effects of inhibition of phosphodiesterase 3 and 5 on cardiac function and interstitial fibrosis in rats with isoproterenol-induced cardiac dysfunction. J Cardiovasc Pharmacol 73:195–205

    Google Scholar 

  • Narita T, Suzuki K (2015) Bone marrow-derived mesenchymal stem cells for the treatment of heart failure. Heart Fail Rev 20:53–68

    Google Scholar 

  • Naseroleslami M et al (2021) Lavender oil attenuates myocardial ischemia/reperfusion injury through inhibition of autophagy and stimulation of angiogenesis. Iran J Sci Technol Trans A: Sci 45(4):1201–1209

    Google Scholar 

  • Pang L-X, Cai W-W, Li Q, Li H-J, Fei M, Yuan Y-S, Sheng B, Zhang K, An R-C, Ying-Wei O (2021) Bone marrow-derived mesenchymal stem cells attenuate myocardial ischemia–reperfusion injury via upregulation of splenic regulatory T cells. BMC Cardiovasc Disord 21:1–12

    Google Scholar 

  • Park J, Lee JH, Yoon BS, Jun EK, Lee G, Kim IY, You S (2018) ’Additive effect of bFGF and selenium on expansion and paracrine action of human amniotic fluid-derived mesenchymal stem cells. Stem Cell Res Therapy 9:1–17

    Google Scholar 

  • Rasti A, Mehrazma M, Madjd Z, Abolhasani M, Zanjani LS, Asgari M (2018) ’Co-expression of cancer stem cell markers OCT4 and NANOG predicts poor prognosis in renal cell carcinomas. Sci Reports 8:1–11

    Google Scholar 

  • Seo H-H, Lee Se-Y, Lee CY, Kim R, Kim P, Sekyung O, Lee H, Lee MY, Kim J, Kim LK (2017) Exogenous miRNA-146a enhances the therapeutic efficacy of human mesenchymal stem cells by increasing vascular endothelial growth factor secretion in the ischemia/reperfusion-injured heart. J Vasc Res 54:100–108

    Google Scholar 

  • Sharifi M, Nazarinia D, Ramezani F, Azizi Y, Naderi N, Aboutaleb N (2021) Necroptosis and RhoA/ROCK pathways: molecular targets of Nesfatin-1 in cardioprotection against myocardial ischemia/reperfusion injury in a rat model. Mol Biol Reports 48:2507–2518

    Google Scholar 

  • Shi M, Zhao F, Sun L, Tang F, Gao W, Xie W, Cao X, Zhuang J, Chen X (2021) Bioactive glass activates VEGF paracrine signaling of cardiomyocytes to promote cardiac angiogenesis. Mater Sci Eng C 124:112077

    Google Scholar 

  • Sid-Otmane C, Perrault LP, Ly HQ (2020) Mesenchymal stem cell mediates cardiac repair through autocrine, paracrine and endocrine axes. J Trans Med 18:1–9

    Google Scholar 

  • Simic P, Zainabadi K, Bell E, Sykes DB, Saez B, Lotinun S, Baron R, Scadden D, Schipani E, Guarente L (2013) SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating β-catenin. EMBO Mol Med 5:430–440

    Google Scholar 

  • Simko F, Bednarova KR, Krajcirovicova K, Hrenak J, Celec P, Kamodyova N, Gajdosechova L, Zorad S, Adamcova M (2014) Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure. J Pineal Res 57:177–184

    Google Scholar 

  • Tousi SM, Razavi T, Faghihi M, Nobakht M, Molazem M, Kalantari E, Azar AD, Aboutaleb N (2016) Improvement of heart failure by human amniotic mesenchymal stromal cell transplantation in rats. J Tehran Univ Heart Center 11:123

    Google Scholar 

  • Tsuji-Tamura K, Ogawa M (2018) Morphology regulation in vascular endothelial cells. Inflam Regen 38(1):1–13

    Google Scholar 

  • Watanabe M, Horie H, Kurata Y, Inoue Y, Notsu T, Wakimizu T, Adachi M, Yamamoto K, Morikawa K, Kuwabara M (2021) Esm1 and Stc1 as angiogenic factors responsible for protective actions of adipose-derived stem cell sheets on chronic heart failure after rat myocardial infarction. Circul J 85:657–666

    Google Scholar 

  • Yang J, Zhou W, Zheng W, Ma Y, Lin L, Tang T, Liu J, Jiefeng Yu, Zhou X, Jianguo H (2007) Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology 107:17–29

    Google Scholar 

  • Yun CW, Lee SH (2019) Enhancement of functionality and therapeutic efficacy of cell-based therapy using mesenchymal stem cells for cardiovascular disease. Int J Mol Sci 20:982

    Google Scholar 

  • Zainabadi K (2018) The variable role of SIRT1 in the maintenance and differentiation of mesenchymal stem cells. Regen Med 13:343–356

    Google Scholar 

  • Zhang H, He S, Spee C, Ishikawa K, Hinton DR (2015) SIRT1 mediated inhibition of VEGF/VEGFR2 signaling by Resveratrol and its relevance to choroidal neovascularization. Cytokine 76:549–552

    Google Scholar 

  • Zhang X-J, Tan H, Shi Z-F, Li N, Jia Y, Hao Z (2019) Growth differentiation factor 11 is involved in isoproterenol-induced heart failure. Mol Med Reports 19:4109–4118

    Google Scholar 

Download references

Acknowledgements

Present work was funded by a research grant from Physiology Research Center of Iran University of Medical Sciences.

Funding

The authors did not receive support from any organization for the submitted work.

Author information

Authors and Affiliations

  1. Department of Cardiology, Cardiovascular Diseases Research Center, School of Medicine, Heshmat Hospital, Guilan University of Medical Sciences, Rasht, Iran

    Seyed Mohammad Taghi Razavi Tousi

  2. Department of Cellular and Molecular Biology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

    Maryam Naseroleslami

  3. Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran

    Masoomeh Sharifi, Yaser Azizi & Nahid Aboutaleb

  4. Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

    Masoomeh Sharifi & Nahid Aboutaleb

Authors
  1. Seyed Mohammad Taghi Razavi Tousi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masoomeh Sharifi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maryam Naseroleslami
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yaser Azizi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nahid Aboutaleb
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

NA was involved in conceptualization and study design; SMTRT and MN contributed to investigation and data collection; YA was involved in writing the original draft; NA, SMTRT, YA and MN contributed to writing—review and editing.

Corresponding author

Correspondence to Nahid Aboutaleb.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

The animal use, experimental procedures, and care protocols were approved by School of Medicine Animal Care and Use Committee of Iran University of Medical Sciences. All protocols and animal operation rules were confirmed by the Animal Ethical Committee of Iran University of Medical Sciences.

Consent to Participation

The amniotic membranes were provided from Shahid Akbar Abadi Hospital upon informed consent of the participants in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Consent for Publication

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Razavi Tousi, S.M.T., Sharifi, M., Naseroleslami, M. et al. Mesenchymal Stem Cells Derived from Human Amniotic Membrane Increase VEGF and Extenuate Fibrosis in Heart Failure Rats. Iran J Sci Technol Trans Sci 46, 781–791 (2022). https://doi.org/10.1007/s40995-022-01307-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40995-022-01307-4

Keywords

Search

Navigation